EDSA8:00 AMEdesa Announces $3.5M Private Placement Led by CEO and Healthcare-Focused Investorsedesabiotech.com
EDSA8:00 AMEdesa Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney InjuryPresentation / Abstract • Phase 3Oral presentation Fri, Jun 5, 2026, 4:30 PM BSTedesabiotech.com
EDSA8:00 AMEdesa Biotech to Present New Data on Paridiprubart in Acute Kidney InjuryPresentation / Abstract • Phase 3Oral presentation Fri, Jun 5, 2026, 4:30 PM local timeedesabiotech.com